Accelerate Diagnostics Revenue Charts (NASDAQ:AXDX)

Add to My Stocks
$27.6 $0.05 (0.18%) AXDX stock closing price Jul 21, 2017 (Closing)
The latest 2017-Q1 Accelerate Diagnostics revenue is 0.5M. Compare Accelerate Diagnostics revenue chart with ArthroCare revenue, Cynosure revenue.

Accelerate Diagnostics Revenue Chart

Quarterly Annual
  • Download
    • Download PNG image
    • Download JPEG image
    • Download SVG image
    • Download PDF document
Embed
Compare with
ARTC revenue
BRKR revenue
CYNO revenue
TMO revenue
You can do annual as well as quarterly comparisons of Accelerate Diagnostics Inc net sales with its competitor companies like ArthroCare, Cynosure. Over the 5 year period Accelerate Diagnostics revenue in 2016 was highest at 0.24M. In the latest quarter, AXDX revenue 2017-Q1 has changed from 0.04M to 0.5M implying an increase of 1150%.

Accelerate Diagnostics Quarterly Revenue

* Past 5 years Range

Max AXDX Revenue $0.5M Mar, 2017
Min AXDX Revenue $0.01M Mar, 2012

Accelerate Diagnostics Annual Revenue

* Past 5 years Range

Max AXDX Revenue $1.12M Dec, 2011
Min AXDX Revenue $0.04M Dec, 2013

Accelerate Diagnostics Annual Revenue VS Peers

2016 2015 2014 2013 2012
Accelerate Diagnostics Revenue $0.24M$0.14M$0.12M$0.04M$1.12M
ArthroCare Revenue ------------$377.98M$368.45M
Cynosure Revenue $433.53M$339.46M$292.36M$226.01M$153.49M
Wafergen Biosystems Revenue ----$7.16M$6M$1.3M$0.58M
Bruker Corp Revenue $1.61B$1.62B$1.81B$1.84B$1.79B
Thermo Fisher Scientific Revenue $18.27B$16.97B$16.89B$13.09B$12.51B
Revenue or net sales is the total amount of money that a company brings in through its various business activities. Revenue is also known as the top line or net sales or gross income. Revenue is for a specific period of time and appears as the "top line" in an income statement. By subtracting the costs or expenses from Accelerate Diagnostics topline we arrive at the bottom line for the company. Increasing revenues over a period of time is generally a sign of a healthy company, however other factors need to be taken into consideration. Revenue can be calculated in two ways based on the type of accounting followed: accrual accounting or cashflow accounting. It helps to compare Accelerate Diagnostics revenue with peers ArthroCare topline, Cynosure topline, Wafergen Biosystems topline; to see how the company is doing with respect to its peers.